Popular Articles

Exploiting Cancer Cell 'Addiction' May Lead To New Therapies
A new study uncovers a gene expression signature that reliably identifies cancer cells whose survival is dependent on a common signaling pathway, even when the cells contain multiple other genetic abnormalities. The research, published by Cell Press in the June 2nd issue of the journal Cancer Cell, identifies critical molecular vulnerabilities, thereby revealing promising therapeutic targets for a common and notoriously treatment resistant cancer.
generic viagra online
CareFirst BCBS Covers ENO Measurement For Diagnosis, Asthma Treatment
Apieron, Inc. said that CareFirst BlueCross BlueShield has adopted a positive coverage policy for the measurement of exhaled nitric oxide (eNO). The Medical Directors of CareFirst determined that the published, peer-reviewed evidence is sufficient to support benefit coverage for the treatment of asthma. The policy, effective July 20, 2009, states the measurement of exhaled nitric oxide is considered medically necessary in the management of asthma patients. CareFirst is the largest health care insurer in the Mid-Atlantic region, serving nearly 3.4 million members in Maryland, District of Columbia and portions of Virginia.
News of the day
PhRMA's Tally: $40 Million To Lobby On Health Care
NPR reports on one of the most powerful players in health care: the Pharmaceutical Research and Manufacturers of America, or PhRMA. In addition to spending $40 million, PhRMA alone has 29 people lobbying for it and has "hired 45 different Washington, D.C., lobbying firms to represent it in those three months of the second quarter."
Mental Health

Pomegranate For Prostate Cancer

Pomegranate juice may be beneficial in men who have undergone standard treatment for localized prostate cancer, according to a long-term study presented at the 104th Annual Scientific Meeting of the American Urological Association. The study, which began in 2003, included 48 men older than age 60 who underwent surgery or radiation therapy to treat localized prostate cancer. All of the men had rising prostate specific antigen (PSA) levels after treatment. PSA is an enzyme that helps break down proteins in the seminal fluid and plays an important role in fertility. Prostate cancer patients often have increased PSA levels, although cancer may occur with any PSA level. Participants drank eight ounces of pomegranate juice daily. During the six-year follow-up, men who continued drinking pomegranate juice had lower PSA levels than those who stopped drinking the juice and were no longer active in the trial. By the end of the study, it took about four times longer for active participants" PSA levels to double than it had at the beginning of the study. References 1. American Urological Association.http://www.auanet.org 2. Natural Standard: The Authority on Integrative Medicine. http://www.naturalstandard.com. Copyright © 2009. 3. Pantuck A, Zomorodian N, Rettig M, et al. Long term follow up of phase 2 study of pomegranate juice for men with prostate cancer shows durable prolongation of PSA doubling time. J Urol, suppl. 2009: 181, 4, abstract 826. Natural Standard


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):